Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,393,739,453
-$119,208,127 QoQ
Shares Held
57,879,546
+7.4% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#10
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. PFE ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
This page
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,393,739,453 | 57,879,546 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,512,947,580 | 53,879,900 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,208,022,764 | 48,514,971 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $890,098,284 | 34,933,214 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $871,860,070 | 35,967,825 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $981,700,503 | 38,741,141 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,059,033,180 | 39,918,326 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,177,166,846 | 40,676,118 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,172,638,211 | 41,909,872 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,176,398,667 | 42,392,745 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $1,269,310,383 | 44,088,586 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,636,896,237 | 49,348,696 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $1,860,980,515 | 50,735,565 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $2,116,141,606 | 51,866,216 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $2,716,073,292 | 53,006,895 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,479,405,665 | 56,659,179 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,953,975,450 | 56,341,321 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $2,828,362,255 | 54,633,229 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $3,228,526,382 | 54,674,452 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,531,974,221 | 58,869,431 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,304,483,406 | 58,847,891 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $2,244,148,399 | 61,941,717 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,383,699,239 | 64,756,839 | Shares | Other | 2021-02-09 | |
| 2020-09-30 | $2,120,940,189 | 57,791,343 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $1,867,559,843 | 57,111,863 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,830,696,746 | 56,087,599 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||